AMPLIPHI BIOSCIENCES CORP(NYSEARCA:APHB) stock News

APHB Latest News, Press Relases and Analysis

All

Press Releases

4 years ago - By: Armata Pharmaceuticals, Inc. - Mentions: ARMP

Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference

5 years ago - By: Armata Pharmaceuticals, Inc. - Mentions: ARMP

Armata Pharmaceuticals Announces the Addition of Robin C. Kramer to its Board of Directors

6 years ago - By: Benzinga - Mentions: INO NBY OPK XBI ...

The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut

6 years ago - By: Benzinga - Mentions: INO NBY OPK XBI ...

The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stock To Debut

6 years ago - By: Armata Pharmaceuticals, Inc. - Mentions: ARMP

C3J Therapeutics and AmpliPhi Biosciences Announce Successful Completion of Merger and Formation of Bacteriophage Company Armata Pharmaceuticals, Inc.

6 years ago - By: AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Announces Stockholder Approval of Business Combination with C3J Therapeutics

6 years ago - By: AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Reports First Quarter 2019 Financial Results and Business Highlights

7 years ago - By: Lifshitz & Miller Law Firm - Mentions: FLKS MYND TISA CCC ...

Lifshitz & Miller LLP Announces Investigation of AmpliPhi Biosciences Corporation, Churchill Capital Corporation, DaVita Inc., Flex Pharma, Inc., MYnd Analytics, Inc., SunCoke Energy Partners, L.P., Top Image Systems Ltd., and Uniti Financial Corporation

7 years ago - By: Monteverde & Associates PC

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of AmpliPhi Biosciences Corporation - APHB

7 years ago - By: Analyst Ratings

Ampliphi Biosciences (APHB) Gets a Buy Rating from H.C. Wainwright

7 years ago - By: AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights

7 years ago - By: Analyst Ratings - Mentions: NBIX

Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX) and Ampliphi Biosciences (AMEX: APHB)

7 years ago - By: AmpliPhi Biosciences Corporation

AmpliPhi Biosciences and C3J Therapeutics Agree to Merge

7 years ago - By: AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Successfully Optimizes Manufacturing Process and Scale Up for AB-SA01 Clinical Development

7 years ago - By: Analyst Ratings

Ampliphi Biosciences (APHB) Receives a Buy from H.C. Wainwright

7 years ago - By: AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Reports Third Quarter 2018 Financial Results and Business Highlights

7 years ago - By: AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Announces Closing of Public Offering

7 years ago - By: AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Announces Pricing of $6.6 Million Underwritten Public Offering

7 years ago - By: AmpliPhi Biosciences

AmpliPhi Biosciences Announces Presentation of Positive Clinical Data From its Expanded Access Program for Serious S. aureus Infections at IDWeek 2018 Conference

7 years ago - By: AmpliPhi Biosciences Corporation

AmpliPhi Biosciences to Present Clinical Case Series Data at IDWeek 2018

7 years ago - By: AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Announces Positive FDA Feedback for its Clinical Stage Bacteriophage Product Candidate AB-PA01 Targeting Pseudomonas Aeruginosa Infections

7 years ago - By: AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Announces Positive FDA Feedback for its Clinical Stage Bacteriophage Product Candidate AB-SA01

7 years ago - By: AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Announces Updated Positive Clinical Results for its Expanded Access Program

7 years ago - By: AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Reports Second Quarter 2018 Financial Results and Business Highlights

7 years ago - By: Smarter Analyst - Mentions: INGN RDUS

Analysts Offer Insights on Healthcare Companies: Inogen (APHB), Radius Health (RDUS) and Ampliphi Biosciences (APHB)

7 years ago - By: Analyst Ratings - Mentions: INGN RDUS

Analysts Offer Insights on Healthcare Companies: Inogen (NASDAQ: INGN), Radius Health (NASDAQ: RDUS) and Ampliphi Biosciences (AMEX: APHB)

7 years ago - By: Smarter Analyst - Mentions: TXMD

Analysts Offer Insights on Healthcare Companies: Ampliphi Biosciences (TXMD) and TherapeuticsMD (TXMD)

7 years ago - By: Analyst Ratings - Mentions: TXMD

Analysts Offer Insights on Healthcare Companies: Ampliphi Biosciences (AMEX: APHB) and TherapeuticsMD (NYSE MKT: TXMD)

7 years ago - By: Analyst Ratings - Mentions: TXMD

Analysts Offer Insights on Healthcare Companies: TherapeuticsMD (NYSE MKT: TXMD) and Ampliphi Biosciences (AMEX: APHB)

7 years ago - By: AmpliPhi Biosciences Corporation

AmpliPhi Biosciences Announces Presentation of Bacteriophage Therapy Case Studies at American Society of Microbiology Annual Meeting

7 years ago - By: Analyst Ratings - Mentions: MGEN MESO

Analysts Offer Insights on Healthcare Companies: Miragen Therapeutics Inc (NASDAQ: MGEN), Mesoblast Ltd (NASDAQ: MESO) and Ampliphi Biosciences (AMEX: APHB)

7 years ago - By: AmpliPhi Biosciences Corporation

AMPLIPHI BIOSCIENCES CORP (APHB) Stock News

APHB Latest News, Press Relases and Analysis

Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference

Armata Pharmaceuticals Announces the Addition of Robin C. Kramer to its Board of Directors

The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut

The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stock To Debut

C3J Therapeutics and AmpliPhi Biosciences Announce Successful Completion of Merger and Formation of Bacteriophage Company Armata Pharmaceuticals, Inc.

AmpliPhi Biosciences Announces Stockholder Approval of Business Combination with C3J Therapeutics

AmpliPhi Biosciences Reports First Quarter 2019 Financial Results and Business Highlights

Lifshitz & Miller LLP Announces Investigation of AmpliPhi Biosciences Corporation, Churchill Capital Corporation, DaVita Inc., Flex Pharma, Inc., MYnd Analytics, Inc., SunCoke Energy Partners, L.P., Top Image Systems Ltd., and Uniti Financial Corporation

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of AmpliPhi Biosciences Corporation - APHB

Ampliphi Biosciences (APHB) Gets a Buy Rating from H.C. Wainwright

AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights

Analysts Offer Insights on Healthcare Companies: Neurocrine (NASDAQ: NBIX) and Ampliphi Biosciences (AMEX: APHB)

AmpliPhi Biosciences and C3J Therapeutics Agree to Merge

AmpliPhi Biosciences Successfully Optimizes Manufacturing Process and Scale Up for AB-SA01 Clinical Development

Ampliphi Biosciences (APHB) Receives a Buy from H.C. Wainwright

AmpliPhi Biosciences Reports Third Quarter 2018 Financial Results and Business Highlights

AmpliPhi Biosciences Announces Closing of Public Offering

AmpliPhi Biosciences Announces Pricing of $6.6 Million Underwritten Public Offering

AmpliPhi Biosciences Announces Presentation of Positive Clinical Data From its Expanded Access Program for Serious S. aureus Infections at IDWeek 2018 Conference

AmpliPhi Biosciences to Present Clinical Case Series Data at IDWeek 2018

AmpliPhi Biosciences Announces Positive FDA Feedback for its Clinical Stage Bacteriophage Product Candidate AB-PA01 Targeting Pseudomonas Aeruginosa Infections

AmpliPhi Biosciences Announces Positive FDA Feedback for its Clinical Stage Bacteriophage Product Candidate AB-SA01

AmpliPhi Biosciences Announces Updated Positive Clinical Results for its Expanded Access Program

AmpliPhi Biosciences Reports Second Quarter 2018 Financial Results and Business Highlights

Analysts Offer Insights on Healthcare Companies: Inogen (APHB), Radius Health (RDUS) and Ampliphi Biosciences (APHB)

Analysts Offer Insights on Healthcare Companies: Inogen (NASDAQ: INGN), Radius Health (NASDAQ: RDUS) and Ampliphi Biosciences (AMEX: APHB)

Analysts Offer Insights on Healthcare Companies: Ampliphi Biosciences (TXMD) and TherapeuticsMD (TXMD)

Analysts Offer Insights on Healthcare Companies: Ampliphi Biosciences (AMEX: APHB) and TherapeuticsMD (NYSE MKT: TXMD)

Analysts Offer Insights on Healthcare Companies: TherapeuticsMD (NYSE MKT: TXMD) and Ampliphi Biosciences (AMEX: APHB)

AmpliPhi Biosciences Announces Presentation of Bacteriophage Therapy Case Studies at American Society of Microbiology Annual Meeting

Analysts Offer Insights on Healthcare Companies: Miragen Therapeutics Inc (NASDAQ: MGEN), Mesoblast Ltd (NASDAQ: MESO) and Ampliphi Biosciences (AMEX: APHB)

AmpliPhi Biosciences Announces Presentation of AB-PA01 Bacteriophage Therapy Case Study at 41st European Cystic Fibrosis Conference